September 25, 2007 – Medical device maker MEDRAD INC. has partnered with the National Prostate Cancer Coalition (NPCC) to provide information about prostate MR imaging to thousands of men who participate in NPCC’s free mobile screening program.

MEDRAD markets an endorectal coil for use in prostate MR that provides pictures of the prostate to assist physicians in diagnosing and staging cancer and planning treatment options. MEDRAD will contribute educational materials about prostate MR, including animation demonstrating the procedure, physician interviews, medical images, a list of hospitals offering the procedure and other information.

Prostate cancer is a growing problem for American men with estimates that one of every six men will get prostate cancer in their lifetime. In addition to offering free prostate cancer screenings with the Drive Against Prostate Cancer mobile screening program, NPCC offers men and their families prostate cancer information and resources through their Website and weekly electronic newsletter, AWARE.

For more information: www.fightprostatecancer.org and www.medrad.com


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Lung Imaging

Oct. 20, 2026 — Optellum has announced that its Virtual Nodule Clinic (VNC) with Lung Cancer Prediction (LCP) AI is ...

Time October 21, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Prostate Cancer

Aug. 13, 2026 — Artera has announced the enrollment of the first patient in its DIRECT-AI registry study, marking the ...

Time August 14, 2026
arrow
News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Subscribe Now